Panacea Biotec Ltd
NSE:PANACEABIO

Watchlist Manager
Panacea Biotec Ltd Logo
Panacea Biotec Ltd
NSE:PANACEABIO
Watchlist
Price: 433.25 INR 0.97%
Market Cap: 26.5B INR
Have any thoughts about
Panacea Biotec Ltd?
Write Note

Panacea Biotec Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Panacea Biotec Ltd
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Panacea Biotec Ltd
NSE:PANACEABIO
Gross Profit
â‚ą3.5B
CAGR 3-Years
-7%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Gross Profit
-â‚ą141.6m
CAGR 3-Years
N/A
CAGR 5-Years
-58%
CAGR 10-Years
N/A
Transgene Biotek Ltd
BSE:526139
Gross Profit
â‚ą2m
CAGR 3-Years
20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Gross Profit
â‚ą194.7m
CAGR 3-Years
-13%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Hester Biosciences Ltd
NSE:HESTERBIO
Gross Profit
â‚ą2.2B
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Biocon Ltd
NSE:BIOCON
Gross Profit
â‚ą99.7B
CAGR 3-Years
26%
CAGR 5-Years
19%
CAGR 10-Years
19%
No Stocks Found

Panacea Biotec Ltd
Glance View

Market Cap
26.5B INR
Industry
Biotechnology

Panacea Biotec Ltd. is a biotechnology company, which is engaged in the business of research, development, manufacture, and marketing of vaccines and pharmaceutical formulations. The company is headquartered in New Delhi, Delhi. The Company’s research areas include new chemical entities (NCE), new biological entities (NBE) novel drug delivery system (NDDS) based pharmaceutical formulations, novel peptides and human monoclonal antibodies and vaccine development. The Company’s product portfolio includes pain management, diabetes & cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, gastrointestinal care products and vaccines. The Company’s subsidiaries include Panacea Biotec Pharma Limited, Panacea Biotec (International) SA, PanEra Biotec Private Limited and Meyten Realtech Private Limited.

PANACEABIO Intrinsic Value
178.94 INR
Overvaluation 59%
Intrinsic Value
Price

See Also

What is Panacea Biotec Ltd's Gross Profit?
Gross Profit
3.5B INR

Based on the financial report for Sep 30, 2024, Panacea Biotec Ltd's Gross Profit amounts to 3.5B INR.

What is Panacea Biotec Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
2%

Over the last year, the Gross Profit growth was 17%. The average annual Gross Profit growth rates for Panacea Biotec Ltd have been -7% over the past three years , 2% over the past five years .

Back to Top